Literature DB >> 1379244

Abnormal localization of cystic fibrosis transmembrane conductance regulator in primary cultures of cystic fibrosis airway epithelia.

G M Denning1, L S Ostedgaard, M J Welsh.   

Abstract

Cystic fibrosis (CF) is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR), a membrane glycoprotein that forms Cl- channels. Previous work has shown that when some CF-associated mutants of CFTR are expressed in heterologous cells, their glycosylation is incomplete. That observation led to the hypothesis that such mutants are not delivered to the plasma membrane where they can mediate Cl- transport. Testing this hypothesis requires localization of CFTR in nonrecombinant cells and a specific determination of whether CFTR is in the apical membrane of normal and CF epithelia. To test the hypothesis, we used primary cultures of airway epithelia grown on permeable supports because they polarize and express the CF defect in apical Cl- permeability. Moreover, their dysfunction contributes to disease. We developed a semiquantitative assay, using nonpermeabilized epithelia, an antibody directed against an extracellular epitope of CFTR, and large (1 microns) fluorescent beads which bound to secondary antibodies. We observed specific binding to airway epithelia from non-CF subjects, indicating that CFTR is located in the apical membrane. In contrast, there was no specific binding to the apical membrane of CF airway epithelia. These data were supported by qualitative studies using confocal microscopy: the most prominent immunostaining was in the apical region of non-CF cells and in cytoplasmic regions of CF cells. The results indicate that CFTR is either missing from the apical membrane of these CF cells or it is present at a much reduced level. The data support the proposed defective delivery of some CF-associated mutants to the plasma membrane and explain the lack of apical Cl- permeability in most CF airway epithelia.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1379244      PMCID: PMC2289545          DOI: 10.1083/jcb.118.3.551

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  32 in total

1.  Chloride conductance expressed by delta F508 and other mutant CFTRs in Xenopus oocytes.

Authors:  M L Drumm; D J Wilkinson; L S Smit; R T Worrell; T V Strong; R A Frizzell; D C Dawson; F S Collins
Journal:  Science       Date:  1991-12-20       Impact factor: 47.728

2.  Structural analysis of a human intestinal epithelial cell line.

Authors:  J L Madara; J Stafford; K Dharmsathaphorn; S Carlson
Journal:  Gastroenterology       Date:  1987-05       Impact factor: 22.682

3.  Expression and characterization of the cystic fibrosis transmembrane conductance regulator.

Authors:  R J Gregory; S H Cheng; D P Rich; J Marshall; S Paul; K Hehir; L Ostedgaard; K W Klinger; M J Welsh; A E Smith
Journal:  Nature       Date:  1990-09-27       Impact factor: 49.962

4.  Localization of the cystic fibrosis transmembrane conductance regulator in pancreas.

Authors:  C R Marino; L M Matovcik; F S Gorelick; J A Cohn
Journal:  J Clin Invest       Date:  1991-08       Impact factor: 14.808

5.  Maturation and function of cystic fibrosis transmembrane conductance regulator variants bearing mutations in putative nucleotide-binding domains 1 and 2.

Authors:  R J Gregory; D P Rich; S H Cheng; D W Souza; S Paul; P Manavalan; M P Anderson; M J Welsh; A E Smith
Journal:  Mol Cell Biol       Date:  1991-08       Impact factor: 4.272

6.  Identification and regulation of the cystic fibrosis transmembrane conductance regulator-generated chloride channel.

Authors:  H A Berger; M P Anderson; R J Gregory; S Thompson; P W Howard; R A Maurer; R Mulligan; A E Smith; M J Welsh
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

7.  Effect of deleting the R domain on CFTR-generated chloride channels.

Authors:  D P Rich; R J Gregory; M P Anderson; P Manavalan; A E Smith; M J Welsh
Journal:  Science       Date:  1991-07-12       Impact factor: 47.728

8.  Nucleoside triphosphates are required to open the CFTR chloride channel.

Authors:  M P Anderson; H A Berger; D P Rich; R J Gregory; A E Smith; M J Welsh
Journal:  Cell       Date:  1991-11-15       Impact factor: 41.582

9.  Generation of cAMP-activated chloride currents by expression of CFTR.

Authors:  M P Anderson; D P Rich; R J Gregory; A E Smith; M J Welsh
Journal:  Science       Date:  1991-02-08       Impact factor: 47.728

10.  Localization of cystic fibrosis transmembrane conductance regulator in chloride secretory epithelia.

Authors:  G M Denning; L S Ostedgaard; S H Cheng; A E Smith; M J Welsh
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

View more
  50 in total

1.  Impact of heterogeneity within cultured cells on bacterial invasion: analysis of Pseudomonas aeruginosa and Salmonella enterica serovar typhi entry into MDCK cells by using a green fluorescent protein-labelled cystic fibrosis transmembrane conductance regulator receptor.

Authors:  A A Gerçeker; T Zaidi; P Marks; D E Golan; G B Pier
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

2.  Activation mechanisms for the cystic fibrosis transmembrane conductance regulator protein involve direct binding of cAMP.

Authors:  Malcolm M C Pereira; Jody Parker; Fiona L L Stratford; Margaret McPherson; Robert L Dormer
Journal:  Biochem J       Date:  2007-07-01       Impact factor: 3.857

3.  Side chain and backbone contributions of Phe508 to CFTR folding.

Authors:  Patrick H Thibodeau; Chad A Brautigam; Mischa Machius; Philip J Thomas
Journal:  Nat Struct Mol Biol       Date:  2004-12-26       Impact factor: 15.369

4.  Sildenafil (Viagra) corrects DeltaF508-CFTR location in nasal epithelial cells from patients with cystic fibrosis.

Authors:  R L Dormer; C M Harris; Z Clark; M M C Pereira; I J M Doull; C Norez; F Becq; M A McPherson
Journal:  Thorax       Date:  2005-01       Impact factor: 9.139

Review 5.  Cystic fibrosis: a brief look at some highlights of a decade of research focused on elucidating and correcting the molecular basis of the disease.

Authors:  Y H Ko; P L Pedersen
Journal:  J Bioenerg Biomembr       Date:  2001-12       Impact factor: 2.945

Review 6.  Frontiers in research on cystic fibrosis: understanding its molecular and chemical basis and relationship to the pathogenesis of the disease.

Authors:  Y H Ko; P L Pedersen
Journal:  J Bioenerg Biomembr       Date:  1997-10       Impact factor: 2.945

7.  Characterization of an allele-nonspecific intragenic suppressor in the yeast plasma membrane H+-ATPase gene (Pma1).

Authors:  A M Maldonado; N de la Fuente; F Portillo
Journal:  Genetics       Date:  1998-09       Impact factor: 4.562

8.  Processing and function of CFTR-DeltaF508 are species-dependent.

Authors:  Lynda S Ostedgaard; Christopher S Rogers; Qian Dong; Christoph O Randak; Daniel W Vermeer; Tatiana Rokhlina; Philip H Karp; Michael J Welsh
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-14       Impact factor: 11.205

9.  Localization studies of rare missense mutations in cystic fibrosis transmembrane conductance regulator (CFTR) facilitate interpretation of genotype-phenotype relationships.

Authors:  Kristina V Krasnov; Maria Tzetis; Jie Cheng; William B Guggino; Garry R Cutting
Journal:  Hum Mutat       Date:  2008-11       Impact factor: 4.878

10.  CFTR and differentiation markers expression in non-CF and delta F 508 homozygous CF nasal epithelium.

Authors:  F Dupuit; N Kälin; S Brézillon; J Hinnrasky; B Tümmler; E Puchelle
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.